BURLINGAME, Calif., October 13, 2026--āshibio presented new clinical biomarker and genetic prevalence data supporting the development of vantictumab for ADO2 at ASBMR 2026.

This activity was supported by Contract/Task Order No. 28321318D00060015/00003 between the National Academy of Sciences and the U.S. Social Security Administration. Any opinions, findings, conclusions ...

Studying the cells of people and genetically engineered mice, scientists say they have uncovered a potential reason why patients with Loeys-Dietz syndrome, an inherited connective tissue disorder, are ...

Nearly 1 in 3 patients with systemic lupus erythematosus (SLE) are taking a supplement-medication combination with potential for an interaction, according to a study published online Sept. 22 in ...

To compare spinal and pelvic parameters obtained on a full spine x-ray in standing position using the EOS®system, between individuals with Marfan syndrome with and those without dural ectasia. We ...

Illinois teen Brennan Saele was diagnosed with vascular Ehler-Danlos syndrome just two years ago, after his mom received her own diagnosis ...

For people living with autoimmune connective tissue diseases, the question of whether to have children is rarely a simple one ...